Showing 1 - 5 results of 5 for search 'Nansheng Cheng', query time: 0.02s Refine Results
  1. 1
    Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy

    Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy by Di Zeng, Di Zeng, Saud Ahmad Saad, Saud Ahmad Saad, Zhen You, Zhen You, Nansheng Cheng, Nansheng Cheng

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Evaluating body roundness index and systemic immune inflammation index for mortality prediction in MAFLD patients

    Evaluating body roundness index and systemic immune inflammation index for mortality prediction in MAFLD patients by Di Zeng, Qingyue Zeng, Shuangqing Li, Jiong Lu, Nansheng Cheng

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Short-term and Long-term Clinical Outcomes of Combined Caudate Lobectomy for Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus: A Propensity Score Analysis

    Short-term and Long-term Clinical Outcomes of Combined Caudate Lobectomy for Intrahepatic Cholangiocarcinoma Involving the Hepatic Hilus: A Propensity Score Analysis by Di Zeng, Yaoqun Wang, Ningyuan Wen, Bei Li, Nansheng Cheng, Jiong Lu

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study

    Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study by Di Zeng, Shaofeng Wang, Nansheng Cheng, Bei Li, Xianze Xiong, Jiong Lu

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study.

    Exploring the combined impact of hepatitis B antibody status and systemic immune-inflammation index on mortality risk: A population-based study. by Di Zeng, Shaofeng Wang, Nansheng Cheng, Bei Li, Xianze Xiong, Jiong Lu

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: